Piperacillin-tazo 3.375 g dplxs
Ended Awarded Last action
- Contract number
- SPE2DR26F9JZ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,097
Award facts
- Contract value 100% obligated
- $3,097.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,097.32 to AmerisourceBergen Drug Corp for the supply of Piperacillin-Tazobactam 3.375G DPLXS, a combination antibiotic commonly used in hospital and military healthcare settings. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and was issued on January 7, 2026, with an ultimate completion date of January 8, 2026. The product will be delivered to the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply an extensive portfolio of pharmaceutical products and medical commodities—including brand-name and generic medications, vaccines, medical devices, and specialized healthcare supplies—to support military healthcare programs globally. The IDC vehicle demonstrates the contractor's capability to meet federal procurement requirements across multiple therapeutic domains and serve customers including the Defense Health Agency and U.S. Coast Guard through flexible ordering mechanisms.
Quick answers
Who was awarded contract SPE2DR26F9JZ4?
SPE2DR26F9JZ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9JZ4 worth?
The government has obligated $3,097 on SPE2DR26F9JZ4.
Is contract SPE2DR26F9JZ4 an order under another contract?
Yes. SPE2DR26F9JZ4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JZ4 competed?
The extent of competition for SPE2DR26F9JZ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award